All Categories APDN in the News Corporate/Financial News Investors Large-Scale DNA Production Linear DNA Press Release Uncategorized Vaccines

Category: Press Release

Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection

March 19th, 2020

Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models

March 18th, 2020

Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed

March 2nd, 2020

Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products

February 20th, 2020

Applied DNA Enters Dietary Supplements Market with Multi-year Nutrition21 Contract

February 19th, 2020

Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV

February 7th, 2020

Applied DNA Reports FY’20 Q1 Results

February 6th, 2020

APDN Schedules FY’20 Q1 Financial Results Conference Call

January 30th, 2020

Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials

January 27th, 2020